Company intelligence / Profile preview
Tolmar
Fort Collins, Colorado, USAtolmar.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Tolmar’s lead product ELIGARD® (leuprolide acetate for injectable suspension) uses the proprietary Atrigel delivery system and is approved for advanced prostate cancer. The company also manufactures and develops other long-acting injectable therapies in endocrinology and urology. Clinical results have established ELIGARD as an effective LHRH agonist for testosterone suppression in prostate cancer patients; it has been commercialized globally with ongoing collaborations to expand access.
- Therapeutic areas
- OncologyEndocrinology
- Modalities
- Long-acting injectablesSynthetic peptides (e.g., leuprolide acetate)Small molecules
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Sanofi Canada – collaboration on Eligard commercialization in CanadaAstellas Pharma – previous agreement for Eligard rights outside North America; rights returned to Tolmar in some regions recently.
Beyond the preview
Go deeper on Tolmar.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tolmar.